Structural basis for antibiotic resistance by chloramphenicol acetyltransferase type A in Staphylococcus aureus

  24 October 2025

The authors solved the first crystal structure of the enzyme chloramphenicol acetyltransferase 1 (saCAT1) from Staphylococcus aureus, showing how the enzyme binds and modifies the antibiotic chloramphenicol (by acetylation) to prevent it from attaching to the bacterial ribosome, thereby rendering the drug ineffective. They detail key active‐site residues and measure kinetic parameters (Km ~ 16.9 µM for chloramphenicol; Ki ~ 83.7 µM for the inhibitor fusidic acid), highlighting that the inhibitor’s effect is limited and pointing to the enzyme structure as a foundation for designing new inhibitors or therapies to counteract this resistance mechanism.

Further reading: Nature Scientific Reports
Author(s): Kaiyue Wang et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!